NM/CT 870 DR

A leading light in clinical discovery

Uncompromised image quality

Improved small lesion detectability with SwiftScan Planar and SwiftScan SPECT¹

Ready for Theranostics

Only scanner with easy, direct upgrade to CZT technology

Enhance producitivity

Simplify workflows for complex procedures with SmartConsole

AI solutions

Several quantitation-based applications, powered by AI on  Xeleris™ V

A fully digital vision for nuclear medicine

NM/CT 870 DR, working alongside our Xeleris workstation, delivers on this vision with a platform that’s ready today to leverage software innovation capable of collecting data to help develop new insights with quantitative analytics. And its modular design makes transitioning to digital detection as simple as exchanging the detector technology.

Additionally, this is a premium SPECT/CT system that delivers the added flexibility of a standalone CT that includes advancements in dose and metal artifact reduction. And it delivers the accurate, reproducible results referring physicians require in a comfortable and streamlined exam experience.

More than a new imaging product, it’s a system for those dedicated to leading clinical discovery with hybrid imaging

NM/CT 870 DR, like all our 800 Series SPECT/CT systems, build on the success of the 600 Series with a collection of SPECT technology enhancements that add to the value of nuclear medicine.

Full spectrum of SPECT/CT capability

In addition to the all-new SmartConsole, NM/CT 870 DR includes a new LEHRS (Low Energy High Resolution and Sensitivity) collimator, which can be combined with either SPECT Step & Shoot Continuous scanning mode or our Planar Clarity 2D processing to increase sensitivity and enable a reduction of scan time or injected dose². It's called SwiftScan Planar and SwiftScan SPECT.

NM/CT 870 DR includes our Elite NXT NM detectors, designed to address some of nuclear medicine’s biggest challenges. It also includes a 20mm CT detector system with IQ Enhancement technology that enables helical coverage speed equivalent to that of a CT scanner at the same table speed³ with a 50-slice wider detector.

These improvements to both SPECT and CT technology are the foundation for quantitative results.

Switch to an all-digital workflow with SmartConsole

Experience new productivity hub for hybrid imaging. By automating SPECT/CT reconstruction, SmartConsole simplifies the workflow for complex hybrid and quantitative protocols and allows technologists to review results directly at the scanner console. It also allows physicians to review scans remotely from mobile devices. They can modify processing settings and initiate study processing anytime, anywhere across a LAN or a WAN*.

SmartConsole enables a noticeable improvement in productivity. Now, a physician can provide their input remotely and digitally. For example, physicians can review a whole-body bone scan directly on their tablet or other mobile device and define the scan range limits they need from wherever they are. The time saved with this switch to a digital workflow helps make it possible to complete exams in predictable time slots.

*Minimum hardware and software requirements apply

One home for all your molecular images

SmartConsole makes advanced procedures more accessible by transferring exams directly to the PACS or other pre-defined DICOM destinations with no operator intervention, even if SPECT/CT fusion is not supported, by exporting the studies in DICOM PET format.

You can generate and send an additional dataset in PET DICOM format to enable quantitative SPECT results and SPECT SUV (Standard Uptake Value) on any PET DICOM compliant workstation or PACS. Referring physicians can review and evaluate your SPECT/CT exams with the same quality of information they have come to expect from your PET/CT, as adjunct information to the original SPECT/CT images.

Modular system design allows you to upgrade your system without having to do a complete system swap

NM/CT 870 DR is ready, because of its modular design, for already-available direct-conversion digital detector technology. What’s more, you have the option to purchase SPECT advancements like SwiftScan Planar and SwiftScan SPECT now, or in the future. The same goes for your CT with the ability to add features like ASiR™ at a later date, when it best suits your practical application. This allows you to acquire the system that fits your needs today knowing that we can help you easily and cost-effectively upgrade your capital investment if your practice requires it.

Quantitative SPECT/CT for every patient, every day

NM/CT 870 DR is a SPECT/CT built for consistent, reproducible quantitation. Improvements to detector performance enable exceptional spatial resolution for SPECT and planar images. It leverages CT-based attenuation and scatter correction along with Evolution⁴ image reconstruction. Ever-increasing computational power enables precise camera calibration for less variation between exams.

Once your quantitative studies are acquired, SmartConsole with Xeleris, makes it easier to access them - your quantitative SPECT/CT studies are automatically transferred directly to the PACS or other pre-defined DICOM destinations. An additional dataset in PET DICOM format allows you to review and evaluate images on the same devices you use to view your PET/CT studies, as adjacent information to the original SPECT/CT images.

Additional benefits provided by NM/CT 870 DR

Saves time and steps

Remotely collaborate with a clinician mid-exam

Complete exams in predictable time slots

Helping NM departments operate efficiently

Therapy monitoring

Leveraging quantitative disease state and treatment response assessments

One home for all your images

Improve workflow with automated transfer and archive features

Improve patient experience

NM/CT 870 DR was designed to help you spend more time with your patients.

SPECT dose management

Evolution technology4 provides up to 50 percent reduction in injected dose or scan time, allowing shorter, more tolerable exams for greater patient comfort.

CT Smart Dose Technology

Enhance patient satisfaction with ASiR and VISR5, which help achieve your low-dose CT needs. Maintain quantitative SPECT accuracy when corrected by low-dose CT with Q.AC6.

  1. As demonstrated in phantom testing using a model observer. For SPECT, compared to using the LEHR Collimator and a SPECT Step & Shoot acquisition. For Planar, compared to using LEHR without Clarity 2D.
  2. Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/ dose for the particular clinical task.
  3. Image quality as defined by an Artifact Index in Phantom testing. Data on file.
  4. In clinical practice, Evolution options4a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit4b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.

    4a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.

    4b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
  5. In clinical practice, the use of ASiR or VISR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.
  6. Quantitative accuracy defined as equivalence to well counter-measured injected activity in a test phantom. Equivalence means < 11% difference when comparing measured counts in SPECT studies corrected by Q.AC-reconstructed CTAC to measured counts in studies corrected by benchmark reconstructed CTAC. Measured counts are defined as average within identical ROIs positioned on SPECT reconstructed slices of homogenous 99mTc solution phantom study.

Have a question? We would love to hear from you.